Examining the Long-term Clinical Evidence of Therapies for Inflammatory Bowel Disease in Bio-naïve Patients : Episode 17
Biosimilar Treatment Options for Patients With UC
Experts discuss the recent use of biosimilars like inolimomab as treatment for ulcerative colitis (UC).
EP: 1.Overview of IBD
EP: 2.Treatment Factors of IBD
EP: 3.Managing Care for IBD Patients Not Responding to Treatment
EP: 4.Selecting First-Line Treatments for CD
EP: 5.The Role of Vedolizumab and Risankizumab in CD
EP: 6.Efficacy and Safety of Ustekinumab for CD
EP: 7.Selecting Therapies for CD in Pregnancy
EP: 8.Selecting Treatments in Patients With EIM
EP: 9.Second-Line Therapies for CD
EP: 10.Optimizing Therapies for CD
EP: 11.Major Takeaways for Treating CD
EP: 12.Treatment Approaches for Patients With UC
EP: 13.The Role of Ozanimod in UC
EP: 14.The Role of Ustekinumab in UC
EP: 15.Utilizing JAK Inhibitors in Patients With UC
EP: 16.Treatment Sequencing for UC
Now Viewing
EP: 17.Biosimilar Treatment Options for Patients With UC
EP: 18.Key Takeaways and Prospective Treatment Advances
Related Videos
Related Content
